Friday, July 31, 2026

Putin’s Youth Army in Pyongyang? North Korea and Russia Cement ‘Eternal Comradeship’

North Korea and Russia held a youth solidarity gathering, emphasizing ideological unity and support against Western hegemony.

North Korean Military Violated MDL 10 Times In November Alone, Concentrated In Goseong Gangwon

North Korean forces have violated the Military Demarcation Line multiple times, prompting South Korean military responses without protocol changes.

North Korea’s Future at Stake: What the Iran Conflict Means for Kim Jong Un

Jang Dong-hyuk warns of North Korea's nuclear ambitions amid U.S.-Iran conflict, criticizing President Lee's North Korea policy and judicial reforms.

Tag: K-bio

[Interview] Excelthera Expands Portfolio With Immune Cell Culture Media, Accelerating Global Partnership Efforts

Excelthera aims to expand globally by launching new immune cell culture media and seeking global partners for collaboration.

KDDF Chief Calls for Structural Shift in Korea Biotech Beyond Technology Transfer

Dr. Park Young-min urges South Korea's biotech sector to shift from tech transfer to global collaboration for sustainable growth.

Korean MSD Partners with 13 Biotech Firms to Act as Global Collaboration Hub

Korean MSD held an Open Innovation Week to enhance collaboration with local biotech firms, aiming for technology exchanges and joint research.

Cha Biotech Announces Support of K-Bio Startups at Bio Korea 2026

Cha Biotech aims to create a global innovation ecosystem for K-Bio startups through the K-Bio CIC Open Innovation Center.

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Top News

- Our Sponsors Ad -

Follow us